about
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate CancerG56W1 in Women With Postmenopausal OsteoporosisStudy of the Effectiveness of ETIASA® (Sustained Release 5-Aminosalicylate) in Maintenance Treatment of Ulcerative Colitis (UC)Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic ArthritisPreoperative Vitamin B12 and Folic Acid on POCD in Elderly Non-cardiac Surgical PatientsStudy of rhPro-UK in Patients With Acute Ischaemic Stroke in 4.5 Hours After Stroke Onset(PROST)Safety and Efficacy Study Using Gene Therapy for Critical Limb IschemiaPersonalized Peroral Endoscopic Myotomy for AchalasiaStudy of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) PatientsThe Efficacy and Safety of Collagen Scaffold Loaded With Umbilical Cord Derived Mesenchymal Stem Cells in Infertile Women With Thin Endometrium or Endometrial ScarringA Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal CancerStudy of BGB-290 or Placebo in Patients With Advanced or Inoperable Gastric CancerA Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene AberrationsA Follow-up Study Investigating Long Term Treatment With Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)A Tiered Management System of Osteoporosis in China
P6153
Q41596747-5ACE44E0-427C-48D6-983B-6F3EA15E952AQ55221670-13e6d949-47e6-a479-e845-e7cb5f86a080Q56191638-251DD77E-8B23-4FA2-BA5C-B49BDFD6754BQ56938924-93AAAD60-928B-4DDC-ACEB-F62B74C07B7EQ59546552-F48B06C2-1045-4750-A252-BF3AAA2D7BF7Q59678423-F2FF8F38-E3AC-4281-B672-1F8B7FA8DA2AQ59681512-F9B067C5-1D82-4A96-A3C2-476D0F46B85DQ59685264-A7702094-C3B2-4490-8C82-35A10EAF2921Q61103620-B45DC5C0-E8D9-410A-AA14-47F109566BF9Q61158562-361341CF-F26D-4228-968E-8FE04484F608Q85484060-015AC581-AB2D-4137-81E8-EC1675F32FBDQ85503983-2C01B416-438F-498B-ADBC-36E24ECC1FEDQ85503983-89A75AC6-A201-464A-9919-2E08789C3D14Q87250915-43801A95-2F34-43BC-B8B3-6F4DB83C21FFQ87856764-136C6103-CD28-4D00-894B-0AA22E76324FQ87943240-DE8FF4F1-5A06-4FA9-A60D-EC03636932E5Q88357653-325E82F1-04FF-4135-A20A-30F706EF7AFEQ88769926-6B8AF467-4C16-4B67-96A3-E40A5B56C996Q88939858-9225841E-4DEA-44F2-AE3E-3654D84A6103Q88990137-628ABF40-FB8B-453D-8293-6CBF85F1D1C8Q89395641-AAF85975-DC1C-4C3A-980F-425520332E22Q90069884-4B1752D4-AD28-4F24-BF87-BCC40C38FE35
P108
Q62034171-0D6EC4DB-E3DD-462F-8F2E-93E02CCE9F4BQ62039821-BD4292A8-B885-41F2-9FF6-BA65ECB00831Q62054228-1EE8C4CD-B9F6-405A-893B-9D18E57F92DEQ62809276-7CDDA24D-B32B-46D9-A928-733D69C162EBQ62809601-A4BF6543-D055-464A-8C34-FE215C5948C6Q62811706-8A7D7DDE-9743-4A54-B326-CC2BBF04D3F5Q63316408-4E0FDB86-B774-4090-8C84-2909C84A69D3Q63316831-7DB71D76-9BF0-4655-9751-734CD1A4D732Q63318975-F93B40DF-2840-4F20-854C-EA0C61828BB7Q63395083-83D86350-77CD-462A-A773-71E8E4C58CBAQ63397199-F9C6B5E0-DCB0-42EA-9DE1-4F7533817E53Q63401153-6EA1E19D-FD21-4CF3-A15F-EB14FA0604A0Q63405227-0BBC33D6-706D-4B2F-989B-FF40795C88E7Q64139334-135308E2-2502-4A6D-8FB5-749078C311BEQ64140063-656B5BC7-2A93-4FEB-9D7D-CBE50D6029B7Q64171227-54A70CCC-D6B8-4E9B-B02B-176AB7857BB7
P6153
description
griya sakit
@jv
healthcare organization in Nanjing, China
@en
rumah sakik
@min
rumah sakit di Republik Rakyat Tiongkok
@id
rumoh sakét
@ace
مستشفى في نانجينغ، الصين
@ar
name
Nanjing Drum Tower Hospital
@en
type
label
Nanjing Drum Tower Hospital
@en
altLabel
Affiliated Hospital of Nanjing University Medical School
@en
Nanjing Gulou Yi Yuan
@en
Nanjing Red Cross Central Hospital
@en
prefLabel
Nanjing Drum Tower Hospital
@en
P131
P213
0000 0004 1800 1685
P2427
grid.428392.6
P3500
P571
1892-01-01T00:00:00Z
P625
Point (118.783375 32.057314)